(MENAFN- EIN Presswire) EINPresswire/ -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors

Male Hypogonadism Market Growth Forecast: What To Expect By 2025?
The market size for male hypogonadism has significantly expanded in the recent past. The market is set to rise from $3.75 billion in 2024 to $3.95 billion in 2025, maintaining a compound annual growth rate (CAGR) of 5.3%. Factors such as aging populations, growing awareness and diagnosis, lifestyle elements, chronic health conditions, and the pursuit of treatment have contributed to the growth within the historical period.

Anticipations are high for robust expansion in the male hypogonadism market in the coming years. The projections show that its size is set to escalate to ""$4.99 billion in 2029"", with a compound annual growth rate (CAGR) of 6.0%. This anticipated growth during this forecast period is thought to be driven by aspects such as increasing awareness, the prevalence of lifestyle-based health issues, advancements in treatments, concentration on men's health, and a rise in telemedicine and healthcare accessibility. Potential trends over this period will likely shine a spotlight on mental and sexual health, delve into the use of nutraceuticals and lifestyle modifications, extend the market into developing economies, foster cooperative research endeavors, and prioritize long-term security and observation.

Download a free sample of the male hypogonadism market report:

What Are Key Factors Driving The Demand In The Global Male Hypogonadism Market?
The rise in infertility rates is predicted to fuel the expansion of the male hypogonadism market in the future. Infertility is a term used to describe a condition that hinders the functioning of the male or female reproductive system, characterized by the failure to conceive after a year or more of regular, unprotected sexual intercourse. Male hypogonadism, which can result in diminished sperm production and infertility, is one of the possible culprits of male infertility. Therefore, the escalating incidence of male infertility is anticipated to stimulate the development of the male hypogonadism market. For example, the Office for National Statistics, a government department in the UK, reported in February 2024 that the total fertility rate (TFR) had risen to 1.49 children per woman in 2022, compared to 1.55 in 2021. Therefore, a surge in infertility rates is propelling the growth of the male hypogonadism market.

Who Are The Leading Players In The Male Hypogonadism Market?
Major players in the Male Hypogonadism include:
. Pfizer Inc.
. Bayer AG
. Eli Lilly and Company Ltd.
. Endo International plc.
. Merck & Co. Inc.
. Ferring Pharmaceuticals
. Finox Biotech AG
. Teva Pharmaceutical Industries Ltd.
. AbbVie Inc.
. Perrigo Company plc.

What Are Some Emerging Trends In The Male Hypogonadism Market?
A prominent trend emerging in the male hypogonadism market revolves around product innovations. Companies within this market are producing new, innovative products in an effort to maintain their competitive market status. For example, in June 2022, the US-based biotechnology company Halozyme introduced Tlando, an orally administered treatment for testosterone replacement therapy in male hypogonadism. Tlando is a prescribed medication consisting of testosterone which holds the distinction of being the first oral testosterone treatment to gain FDA approval. It is designed to treat adult men who, due to certain medical conditions, have low or no testosterone.

Analysis Of Major Segments Driving The Male Hypogonadism Market Growth
The male hypogonadism market covered in this report is segmented –
1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types
2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries
3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy

Subsegments:
1) By Klinefelter's Syndrome: 47,XXY Syndrome, Other Variants
2) By Kallmann Syndrome: Isolated Kallmann Syndrome, Syndromic Kallmann Syndrome
3) By Pituitary Disorders: Hypopituitarism, Pituitary Tumors, Other Pituitary Disorders
4) By Other Types: Androgen Insensitivity Syndrome, Testicular Dysgenesis Syndrome, Genetic Mutations And Disorders

View the full male hypogonadism market report:

Which Region Is Expected To Lead The Male Hypogonadism Market By 2025?
In 2024, North America held the most substantial share of the male hypogonadism market. It is projected that the Asia-Pacific region will experience the most rapid growth during the forecast period. The market report for male hypogonadism includes an analysis of regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Browse Through More Reports Similar to the Global Male Hypogonadism Market 2025, By The Business Research Company

Gastrointestinal Bleeding Treatment Devices Global Market Report 2025

Gastrointestinal Devices Global Market Report 2025

Medical Equipment Maintenance Global Market Report 2025

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email:...
The Business Research Company -

Follow Us On:
. LinkedIn: "

MENAFN23112025003118003196ID1110386254